Exponent (EXPO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on June 5, 2025, with shareholders of record as of April 9, 2025, eligible to vote on key proposals, including director elections, auditor ratification, and executive compensation approval.
Shareholders can vote electronically, by phone, or by mail, and may submit questions in advance or during the meeting.
The Board recommends voting in favor of all proposals and nominees.
Voting matters and shareholder proposals
Six directors are nominated for one-year terms, with a majority vote standard for uncontested elections.
Proposal 2 seeks ratification of KPMG LLP as the independent auditor for fiscal 2025.
Proposal 3 is an advisory vote on 2024 executive compensation; the Board recommends approval.
Shareholders may submit proposals and director nominations for the 2026 meeting, following SEC rules and company bylaws.
Board of directors and corporate governance
The Board consists of six nominees, with a majority deemed independent under Nasdaq standards.
Board committees include Audit, Human Resources, and Nominating and Governance, all composed of independent directors.
The Board held eight meetings in 2024, with all directors attending at least 75% of meetings.
The company separates the CEO and Chairman roles and designates a Lead Independent Director.
The Board has adopted codes of conduct and ethics, and maintains an insider trading policy.
Latest events from Exponent
- Strong Q4 and FY2025 results, with high-single-digit growth and stable margins expected in 2026.EXPO
Q4 20255 Feb 2026 - Q2 2024 net income up 14% on flat revenues, with raised guidance and strong sector demand.EXPO
Q2 20242 Feb 2026 - Q3 net income up 6% to $26M, margin guidance raised, and $0.28 dividend declared.EXPO
Q3 202418 Jan 2026 - Q4 and FY24 results exceeded expectations; 2025 growth to be modest amid headcount recovery.EXPO
Q4 202425 Dec 2025 - Flat Q1 revenue, lower net income, and stable 2025 outlook with rising headcount.EXPO
Q1 202523 Dec 2025 - Q2 2025 revenues up 1%, lower margins, strong dispute-related growth, positive outlook.EXPO
Q2 202516 Nov 2025 - Q3 2025 delivered double-digit revenue growth, higher net income, and raised margin guidance.EXPO
Q3 20257 Nov 2025